Holiday to Set Tone...
Health Care: Drugs
Celsion Corporation (CLSN: NASDAQ)
$0.97 0.03 | 3.19%
05/22/13 - 04:00 PM ET
5.08M / 2.22M
Vol / Avg. Vol:1.02 / 0.94
Open / Prev. Close:0.97 - 1.03
Today's Range:0.75 - 9.44
52 Wk Range:-88.52%
Performance YTD:TheStreet Rating:
Portfolios with CLSN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- UserWatch
- UserBIO
- ContributorStocks Under-$10 Moving Hig...
- Contributor22 Biopharma Stocks With Br...
- ContributorTop 5 Small-Cap Stocks to C...
- ContributorStocks Under-$10 Moving Hig...
Latest CLSN Headlines from TheStreet
- The 5 Dumbest Things on Wall Street This Week 04.26.13 | 07:04 am
- 5 Dumbest Things on Wall Street
04.26.13 | 07:04 am - Celsion's Shameless Spin Job (Update) 04.23.13 | 05:04 pm
- Why This Fund Manager Is Short Ziopharm 03.22.13 | 07:03 am
- 4 Stocks Under $10 Spiking Higher 03.08.13 | 07:03 am
- Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma 02.15.13 | 06:02 am
- Ziopharm's Sarcoma Study And The Feuerstein-Ratain Rule 02.05.13 | 06:02 am
- Stocks Surge After January Jobs Report; Dow Eclipses 14,000 02.01.13 | 02:02 pm
- Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta 02.01.13 | 07:02 am
- Seeking Alpha Author Used Multiple Aliases to Tout Biotech Stocks 01.28.13 | 06:01 am
Press Releases for CLSN
- Celsion Corporation To Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013 - PR Newswire 03.12.13 | 08:03 am
- Celsion Corporation Announces $15 Million Registered Direct Offering - PR Newswire 02.22.13 | 09:02 am
- Celsion Corporation Provides An Update Regarding ThermoDox® Agreements With Zhejiang HISUN Pharmaceutical Company For China - PR Newswire 02.05.13 | 06:02 pm
- Celsion Announces Results Of Phase III HEAT Study Of ThermoDox® In Primary Liver Cancer - PR Newswire 01.31.13 | 07:01 am
- Celsion Corporation To Host Conference Call And Webcast On January 31, 2013 At 8:00 AM EST To Present Top-Line Data From Its Pivotal Phase III HEAT Study - PR Newswire 01.30.13 | 04:01 pm
- Celsion Corporation And Zhejiang Hisun Pharmaceutical Company Enter Into Technology Development Agreement For ThermoDox® For The Greater China Territory - PR Newswire 01.22.13 | 08:01 am
- Celsion Corporation Announces Completion Of $5.1 Million Registered Direct Offering - PR Newswire 01.21.11 | 03:01 pm
Partner Headlines for CLSN
- Amarin & Celsion: Post-Earnings Roundup - Seeking Alpha 05.15.13 | 09:05 am
- Celsion Shares Rally as Co. Hires Cantor Fitzgerald to Evaluate Purchase Alternatives, Study Shows Thermodox Improves PFS with Optimized Heating - Benzinga 04.23.13 | 09:04 am
- 3 Biotechs And The Feuerstein-Ratain Rule - Seeking Alpha 04.09.13 | 09:04 am
- A 2013 Diversified Bullish Portfolio In 10 Positions - Seeking Alpha 02.28.13 | 09:02 am
- After Phase III Failure, Celsion Is Still Worthless - Seeking Alpha 02.12.13 | 09:02 am
- Is Delcath The Post-Celsion Play On Liver Cancer? - Seeking Alpha 02.04.13 | 09:02 am
- Celsion Stock Blown Apart On Thermodox Phase III Data - Seeking Alpha 02.02.13 | 09:02 am
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
- 5 Healthcare Companies With Recent Insider Buying - Seeking Alpha 11.18.12 | 09:11 am
- Pre-Market Earnings Report for November 12, 2012 : DHI, CYD, BZH, CLSN, RRST, CTIB - NASDAQ 11.09.12 | 09:11 pm
